{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T20:43:44Z","timestamp":1794429824427,"version":"4.9.1"},"reference-count":82,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.eururo.2017.12.018","type":"journal-article","created":{"date-parts":[[2018,1,9]],"date-time":"2018-01-09T01:18:06Z","timestamp":1515460686000},"page":"560-569","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":568,"title":["Updates in the Eighth Edition of the Tumor-Node-Metastasis Staging Classification for Urologic Cancers"],"prefix":"10.1016","volume":"73","author":[{"given":"Gladell P.","family":"Paner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter M.","family":"Stadler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna E.","family":"Hansel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo","family":"Montironi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel W.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahul B.","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2017.12.018_bib0420","series-title":"AJCC Cancer Staging Manual","author":"Amin","year":"2017"},{"key":"10.1016\/j.eururo.2017.12.018_bib0430","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3322\/caac.21388","article-title":"The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.eururo.2017.12.018_bib0435","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3322\/caac.21339","article-title":"American Joint Committee on Cancer acceptance criteria for inclusion of risk models for individualized prognosis in the practice of precision medicine","volume":"66","author":"Kattan","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.eururo.2017.12.018_bib0440","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/modpathol.2010.158","article-title":"International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 3: extraprostatic extension, lymphovascular invasion and locally advanced disease","volume":"24","author":"Magi-Galluzzi","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1016\/j.eururo.2017.12.018_bib0445","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/modpathol.2010.178","article-title":"International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 1: specimen handling","volume":"24","author":"Samaratunga","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1016\/j.eururo.2017.12.018_bib0450","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/modpathol.2010.155","article-title":"International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 5: surgical margins","volume":"24","author":"Tan","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1016\/j.eururo.2017.12.018_bib0455","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/modpathol.2010.156","article-title":"International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 2: T2 substaging and prostate cancer volume","volume":"24","author":"van der Kwast","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1016\/j.eururo.2017.12.018_bib0460","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/modpathol.2010.160","article-title":"International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 4: seminal vesicles and lymph nodes","volume":"24","author":"Berney","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1016\/j.eururo.2017.12.018_bib0465","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1097\/PAS.0b013e31829a85d0","article-title":"Handling and staging of renal cell carcinoma: the International Society of Urological Pathology Consensus (ISUP) conference recommendations","volume":"37","author":"Trpkov","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.eururo.2017.12.018_bib0470","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1097\/PAS.0000000000000844","article-title":"Reporting and Staging of Testicular Germ Cell Tumors: The International Society of Urological Pathology (ISUP) Testicular Cancer Consultation Conference Recommendations","volume":"41","author":"Verrill","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.eururo.2017.12.018_bib0475","series-title":"WHO Classification of Tumours of the Urinary System and Male Genital Organs","author":"Moch","year":"2016"},{"key":"10.1016\/j.eururo.2017.12.018_bib0480","unstructured":"CAP Cancer Protocol Templates. Published February 2017. http:\/\/www.cap.org."},{"key":"10.1016\/j.eururo.2017.12.018_bib0485","series-title":"TNM Classification of Malignant Tumours","author":"Brierley","year":"2017"},{"key":"10.1016\/j.eururo.2017.12.018_bib0490","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/his.13200","article-title":"UICC drops the ball in the 8th edition TNM staging of urological cancers","volume":"71","author":"Delahunt","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.eururo.2017.12.018_bib0495","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1097\/PAS.0b013e3181a418ae","article-title":"Comparison of morphologic features and outcome of resected recurrent and nonrecurrent squamous cell carcinoma of the penis: a study of 81 cases","volume":"33","author":"Chaux","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.eururo.2017.12.018_bib0500","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/bju.12677","article-title":"Development and external validation of a prognostic tool for prediction of cancer-specific mortality after complete loco-regional pathological staging for squamous cell carcinoma of the penis","volume":"116","author":"Sun","year":"2015","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2017.12.018_bib0505","doi-asserted-by":"crossref","first-page":"594","DOI":"10.6004\/jnccn.2013.0075","article-title":"Penile cancer: clinical practice guidelines in oncology","volume":"11","author":"Clark","year":"2013","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.eururo.2017.12.018_bib0510","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1097\/PAS.0b013e3181641365","article-title":"Histologic grade and perineural invasion are more important than tumor thickness as predictor of nodal metastasis in penile squamous cell carcinoma invading 5 to 10mm","volume":"32","author":"Velazquez","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.eururo.2017.12.018_bib0515","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.juro.2008.05.011","article-title":"Evaluation of current TNM classification of penile carcinoma","volume":"180","author":"Leijte","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2017.12.018_bib0520","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1038\/bjc.2015.457","article-title":"Modification of N staging systems for penile cancer: a more precise prediction of prognosis","volume":"113","author":"Li","year":"2015","journal-title":"Br J Cancer"},{"key":"10.1016\/j.eururo.2017.12.018_bib0525","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.juro.2011.03.104","article-title":"New N staging system of penile cancer provides a better reflection of prognosis","volume":"186","author":"Zhu","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2017.12.018_bib0530","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.eururo.2014.10.017","article-title":"EAU guidelines on penile cancer: 2014 update","volume":"67","author":"Hakenberg","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2017.12.018_bib0535","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.urolonc.2017.04.009","article-title":"Subclassification of pN3 staging systems for penile cancer: Proposal for modification of the current TNM classification","volume":"35","author":"Li","year":"2017","journal-title":"Urol Oncol"},{"key":"10.1016\/j.eururo.2017.12.018_bib0540","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.juro.2010.09.111","article-title":"Tumor grade improves the prognostic ability of American Joint Committee on Cancer stage in patients with penile carcinoma","volume":"185","author":"Thuret","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2017.12.018_bib0545","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/00000658-192102000-00001","article-title":"Squamous-cell epithelioma of the skin: a study of 256 cases","volume":"73","author":"Broders","year":"1921","journal-title":"Ann Surg"},{"key":"10.1016\/j.eururo.2017.12.018_bib0550","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/S0022-5347(05)66450-6","article-title":"Tumor stage, vascular invasion and the percentage of poorly differentiated cancer: independent prognosticators for inguinal lymph node metastasis in penile squamous cancer","volume":"165","author":"Slaton","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2017.12.018_bib0555","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1097\/01.pas.0000160440.46394.a8","article-title":"Sarcomatoid carcinoma of the penis: a clinicopathologic study of 15 cases","volume":"29","author":"Velazquez","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.eururo.2017.12.018_bib0560","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/PAS.0000000000000530","article-title":"The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: definition of grading patterns and proposal for a new grading system","volume":"40","author":"Epstein","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.eururo.2017.12.018_bib0565","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/PAS.0000000000000820","article-title":"Contemporary Gleason grading of prostatic carcinoma: an update with discussion on practical issues to implement the 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma","volume":"41","author":"Epstein","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.eururo.2017.12.018_bib0570","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.eururo.2015.06.046","article-title":"A contemporary prostate cancer grading system: a validated alternative to the Gleason score","volume":"69","author":"Epstein","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2017.12.018_bib0575","series-title":"Clinically localized prostate cancer: AUA\/ASTRO\/SUO Guideline","author":"Sanda","year":"2017"},{"key":"10.1016\/j.eururo.2017.12.018_bib0580","series-title":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)","year":"2017"},{"key":"10.1016\/j.eururo.2017.12.018_bib0585","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.eururo.2015.07.029","article-title":"Accuracy of magnetic resonance imaging for local staging of prostate cancer: A diagnostic meta-analysis","volume":"70","author":"de Rooij","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2017.12.018_bib0590","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1016\/j.juro.2009.07.020","article-title":"Pathological stage T2 subgroups to predict biochemical recurrence after prostatectomy","volume":"182","author":"Kordan","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2017.12.018_bib0595","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.eururo.2005.12.009","article-title":"The 2002 AJCC pT2 substages confer no prognostic information on the rate of biochemical recurrence after radical prostatectomy","volume":"49","author":"Chun","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2017.12.018_bib0600","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.juro.2011.02.2695","article-title":"Prognostic significance of tumor volume in radical prostatectomy and needle biopsy specimens","volume":"186","author":"Epstein","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2017.12.018_bib0605","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1002\/cncr.20305","article-title":"Does pT2b prostate carcinoma exist? Critical appraisal of the 2002 TNM classification of prostate carcinoma","volume":"100","author":"Eichelberger","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2017.12.018_bib0610","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.humpath.2016.05.016","article-title":"Modification of the pT2 substage classification in prostate adenocarcinoma","volume":"56","author":"Ettel","year":"2016","journal-title":"Hum Pathol"},{"key":"10.1016\/j.eururo.2017.12.018_bib0615","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3322\/caac.21391","article-title":"Prostate cancer\u2014major changes in the American Joint Committee on Cancer eighth edition cancer staging manual","volume":"67","author":"Buyyounouski","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.eururo.2017.12.018_bib0620","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.juro.2017.06.085","article-title":"Independent validation of the American Joint Committee on Cancer 8th Edition prostate cancer staging classification","volume":"198","author":"Bhindi","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2017.12.018_bib0625","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1200\/JCO.2013.52.3696","article-title":"Updated prognostic model for predicting overall survival in first-line chemotherapy for patients with metastatic castration-resistant prostate cancer","volume":"32","author":"Halabi","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2017.12.018_bib0630","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1093\/jnci\/djt280","article-title":"Prognostic model predicting metastatic castration-resistant prostate cancer survival in men treated with second-line chemotherapy","volume":"105","author":"Halabi","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.eururo.2017.12.018_bib0635","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/his.13102","article-title":"The World Health Organization 2016 classification of testicular germ cell tumours: a review and update from the International Society of Urological Pathology Testis Consultation Panel","volume":"70","author":"Williamson","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.eururo.2017.12.018_bib0640","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/cam4.324","article-title":"Evaluation of a prognostic model for risk of relapse in stage I seminoma surveillance","volume":"4","author":"Chung","year":"2015","journal-title":"Cancer Med"},{"key":"10.1016\/j.eururo.2017.12.018_bib0645","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1093\/annonc\/mdu437","article-title":"Prognostic factors for relapse in stage I seminoma: a new nomogram derived from three consecutive, risk-adapted studies from the Spanish Germ Cell Cancer Group (SGCCG)","volume":"25","author":"Aparicio","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.eururo.2017.12.018_bib0650","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.1200\/JCO.2002.01.038","article-title":"Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis","volume":"20","author":"Warde","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2017.12.018_bib0655","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.eururo.2015.07.044","article-title":"Guidelines on Testicular Cancer: 2015 Update","volume":"68","author":"Albers","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2017.12.018_bib0660","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1111\/j.1442-2042.2010.02645.x","article-title":"Outcome of different post-orchiectomy management for stage I seminoma: Japanese multi-institutional study including 425 patients","volume":"17","author":"Kamba","year":"2010","journal-title":"Int J Urol"},{"key":"10.1016\/j.eururo.2017.12.018_bib0665","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.humpath.2010.03.005","article-title":"Rete testis invasion by malignant germ cell tumor and\/or intratubular germ cell neoplasia: what is the significance of this finding?","volume":"41","author":"Vogt","year":"2010","journal-title":"Hum Pathol"},{"key":"10.1016\/j.eururo.2017.12.018_bib0670","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/modpathol.2012.189","article-title":"Testicular hilum and vascular invasion predict advanced clinical stage in nonseminomatous germ cell tumors","volume":"26","author":"Yilmaz","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1016\/j.eururo.2017.12.018_bib0675","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/his.12657","article-title":"Handling and reporting of orchidectomy specimens with testicular cancer: areas of consensus and variation among 25 experts and 225 European pathologists","volume":"67","author":"Berney","year":"2015","journal-title":"Histopathology"},{"key":"10.1016\/j.eururo.2017.12.018_bib0680","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/modpathol.3800726","article-title":"Renal veins and venous extension in clear cell renal cell carcinoma","volume":"20","author":"Bonsib","year":"2007","journal-title":"Mod Pathol"},{"key":"10.1016\/j.eururo.2017.12.018_bib0685","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/PAP.0b013e318032452e","article-title":"Renal cell carcinoma and the renal sinus","volume":"14","author":"Grignon","year":"2007","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.eururo.2017.12.018_bib0690","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1097\/PAS.0b013e318299f0fb","article-title":"The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters","volume":"37","author":"Delahunt","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.eururo.2017.12.018_bib0695","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/his.13311","article-title":"Clear cell renal cell carcinoma: validation of WHO\/ISUP grading","volume":"71","author":"Dagher","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.eururo.2017.12.018_bib0700","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1097\/PAS.0000000000000251","article-title":"Rhabdoid differentiation is associated with aggressive behavior in renal cell carcinoma: a clinicopathologic analysis of 76 cases with clinical follow-up","volume":"38","author":"Przybycin","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.eururo.2017.12.018_bib0705","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1097\/00000478-200010000-00002","article-title":"Renal cell carcinoma with rhabdoid features","volume":"24","author":"Gokden","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.eururo.2017.12.018_bib0710","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.5858\/2002-126-1506-ARRCC","article-title":"Adult rhabdoid renal cell carcinoma","volume":"126","author":"Shannon","year":"2002","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.eururo.2017.12.018_bib0715","doi-asserted-by":"crossref","first-page":"102","DOI":"10.5858\/2007-131-102-RCCWRF","article-title":"Renal cell carcinoma with rhabdoid features: an aggressive neoplasm with overexpression of p53","volume":"131","author":"Leroy","year":"2007","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.eururo.2017.12.018_bib0720","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/PAP.0000000000000152","article-title":"Challenges in pathologic staging of bladder cancer: proposals for fresh approaches of assessing pathologic stage in light of recent studies and observations pertaining to bladder histoanatomic variances","volume":"24","author":"Paner","year":"2017","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.eururo.2017.12.018_bib0725","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.eururo.2009.09.024","article-title":"Characteristics and outcomes of patients with clinical T1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohort","volume":"57","author":"Fritsche","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2017.12.018_bib0730","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.eururo.2006.05.021","article-title":"Discrepancy between clinical and pathologic stage: impact on prognosis after radical cystectomy","volume":"51","author":"Shariat","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2017.12.018_bib0735","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.eururo.2016.05.041","article-title":"EAU Guidelines on Non-muscle-invasive urothelial carcinoma of the bladder: update 2016","volume":"71","author":"Babjuk","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2017.12.018_bib0740","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.humpath.2005.06.017","article-title":"A new system for substaging pT1 papillary bladder cancer: a prognostic evaluation","volume":"36","author":"van der Aa","year":"2005","journal-title":"Hum Pathol"},{"key":"10.1016\/j.eururo.2017.12.018_bib0745","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.eururo.2011.10.026","article-title":"A new and highly prognostic system to discern T1 bladder cancer substage","volume":"61","author":"van Rhijn","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2017.12.018_bib0750","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/PAS.0000000000000964","article-title":"Analysis of T1 bladder cancer on biopsy and transurethral resection specimens: comparison and ranking of T1 quantification approaches to predict progression to muscularis propria invasion","volume":"42","author":"Leivo","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.eururo.2017.12.018_bib0755","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0022-5347(05)64056-6","article-title":"Transitional cell carcinoma involving the prostate: a clinicopathological retrospective study of 76 cases","volume":"169","author":"Njinou Ngninkeu","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2017.12.018_bib0760","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0022-5347(01)65705-7","article-title":"Transitional cell carcinoma involving the prostate with a proposed staging classification for stromal invasion","volume":"156","author":"Esrig","year":"1996","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2017.12.018_bib0765","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0022-5347(01)66605-9","article-title":"Is stage pT4a (D1) reliable in assessing transitional cell carcinoma involvement of the prostate in patients with a concurrent bladder cancer?. A necessary distinction for contiguous or noncontiguous involvement","volume":"155","author":"Pagano","year":"1996","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2017.12.018_bib0770","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.juro.2012.09.006","article-title":"Validation of new AJCC exclusion criteria for subepithelial prostatic stromal invasion from pT4a bladder urothelial carcinoma","volume":"189","author":"Patel","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2017.12.018_bib0775","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/bju.12486","article-title":"Urothelial carcinoma involving the prostate: the association of revised tumour stage and coexistent bladder cancer with survival after radical cystectomy","volume":"114","author":"Knoedler","year":"2014","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2017.12.018_bib0780","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1016\/j.humpath.2011.02.022","article-title":"Limited smoothelin expression within the muscularis mucosae: validation in bladder diverticula","volume":"42","author":"Hansel","year":"2011","journal-title":"Hum Pathol"},{"key":"10.1016\/j.eururo.2017.12.018_bib0785","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1097\/01.ju.0000091800.15071.52","article-title":"Carcinoma in a bladder diverticulum: presentation and treatment outcome","volume":"170","author":"Golijanin","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2017.12.018_bib0790","doi-asserted-by":"crossref","first-page":"791","DOI":"10.5858\/133.5.791","article-title":"Histopathologic features and clinical outcomes in 71 cases of bladder diverticula","volume":"133","author":"Tamas","year":"2009","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.eururo.2017.12.018_bib0795","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1007\/s00345-014-1472-5","article-title":"Urothelial carcinoma in bladder diverticula: outcomes after radical cystectomy","volume":"33","author":"Hu","year":"2015","journal-title":"World J Urol"},{"key":"10.1016\/j.eururo.2017.12.018_bib0800","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1097\/01.ju.0000095804.33714.ea","article-title":"The prognostic significance of metastatic perivesical lymph nodes identified in radical cystectomy specimens for transitional cell carcinoma of the bladder","volume":"170","author":"Bella","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2017.12.018_bib0805","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.urolonc.2014.08.004","article-title":"Significance of perivesical lymph nodes in radical cystectomy for bladder cancer","volume":"32","author":"Hu","year":"2014","journal-title":"Urol Oncol"},{"key":"10.1016\/j.eururo.2017.12.018_bib0810","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1078-1439(02)00182-5","article-title":"Long-term survival in phase II trials of gemcitabine plus cisplatin for advanced transitional cell cancer","volume":"7","author":"Stadler","year":"2002","journal-title":"Urol Oncol"},{"key":"10.1016\/j.eururo.2017.12.018_bib0815","doi-asserted-by":"crossref","first-page":"4602","DOI":"10.1200\/JCO.2005.07.757","article-title":"Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer","volume":"23","author":"von der Maase","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2017.12.018_bib0820","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1200\/JCO.1999.17.10.3173","article-title":"Long-term survival in metastatic transitional-cell carcinoma and prognostic factors predicting outcome of therapy","volume":"17","author":"Bajorin","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2017.12.018_bib0825","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/jnci\/djt015","article-title":"Prognostic model for predicting survival of patients with metastatic urothelial cancer treated with cisplatin-based chemotherapy","volume":"105","author":"Apolo","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.eururo.2017.12.018_bib0830","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1002\/cncr.28146","article-title":"Nomogram for predicting survival in patients with unresectable and\/or metastatic urothelial cancer who are treated with cisplatin-based chemotherapy","volume":"119","author":"Galsky","year":"2013","journal-title":"Cancer"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283817310643?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283817310643?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T20:53:27Z","timestamp":1660251207000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283817310643"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":82,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S0302283817310643"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2017.12.018","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.732451155.793558982","asserted-by":"object"}]},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Updates in the Eighth Edition of the Tumor-Node-Metastasis Staging Classification for Urologic Cancers","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2017.12.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}